These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 3794089

  • 1. Myocardial thallium-201 kinetics and regional flow alterations with 3 hours of coronary occlusion and either rapid reperfusion through a totally patent vessel or slow reperfusion through a critical stenosis.
    Granato JE, Watson DD, Flanagan TL, Beller GA.
    J Am Coll Cardiol; 1987 Jan; 9(1):109-18. PubMed ID: 3794089
    [Abstract] [Full Text] [Related]

  • 2. Myocardial thallium-201 kinetics during coronary occlusion and reperfusion: influence of method of reflow and timing of thallium-201 administration.
    Granato JE, Watson DD, Flanagan TL, Gascho JA, Beller GA.
    Circulation; 1986 Jan; 73(1):150-60. PubMed ID: 3940665
    [Abstract] [Full Text] [Related]

  • 3. Comparison of thallium-201 resting redistribution with technetium-99m-sestamibi uptake and functional response to dobutamine for assessment of myocardial viability.
    Sansoy V, Glover DK, Watson DD, Ruiz M, Smith WH, Simanis JP, Beller GA.
    Circulation; 1995 Aug 15; 92(4):994-1004. PubMed ID: 7641384
    [Abstract] [Full Text] [Related]

  • 4. Kinetics of thallium-201 in reperfused canine myocardium after coronary artery occlusion.
    Okada RD.
    J Am Coll Cardiol; 1984 May 15; 3(5):1245-51. PubMed ID: 6707375
    [Abstract] [Full Text] [Related]

  • 5. Effect of ischemia and postischemic dysfunction on myocardial uptake of technetium-99m-labeled methoxyisobutyl isonitrile and thallium-201.
    Sinusas AJ, Watson DD, Cannon JM, Beller GA.
    J Am Coll Cardiol; 1989 Dec 15; 14(7):1785-93. PubMed ID: 2584570
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The use of preintervention and postintervention thallium imaging for assessing the early and late effects of experimental coronary arterial reperfusion in dogs.
    Okada RD, Pohost GM.
    Circulation; 1984 Jun 15; 69(6):1153-60. PubMed ID: 6713617
    [Abstract] [Full Text] [Related]

  • 9. 99mTc-sestamibi uptake and retention during myocardial ischemia and reperfusion.
    Beller GA, Glover DK, Edwards NC, Ruiz M, Simanis JP, Watson DD.
    Circulation; 1993 Jun 15; 87(6):2033-42. PubMed ID: 8504518
    [Abstract] [Full Text] [Related]

  • 10. Does preconditioning protect the coronary vasculature from subsequent ischemia/reperfusion injury?
    Bauer B, Simkhovich BZ, Kloner RA, Przyklenk K.
    Circulation; 1993 Aug 15; 88(2):659-72. PubMed ID: 8339428
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of 99mTc-teboroxime with thallium for myocardial imaging in the presence of a coronary artery stenosis.
    Gray WA, Gewirtz H.
    Circulation; 1991 Oct 15; 84(4):1796-807. PubMed ID: 1914115
    [Abstract] [Full Text] [Related]

  • 13. Progressive failure of coronary flow during reperfusion of myocardial infarction: documentation of the no reflow phenomenon with positron emission tomography.
    Jeremy RW, Links JM, Becker LC.
    J Am Coll Cardiol; 1990 Sep 15; 16(3):695-704. PubMed ID: 2387943
    [Abstract] [Full Text] [Related]

  • 14. Assessment of thallium-201 redistribution versus glucose uptake as predictors of viability after coronary occlusion and reperfusion.
    Melin JA, Wijns W, Keyeux A, Gurné O, Cogneau M, Michel C, Bol A, Robert A, Charlier A, Pouleur H.
    Circulation; 1988 Apr 15; 77(4):927-34. PubMed ID: 3349587
    [Abstract] [Full Text] [Related]

  • 15. 99mTc-tetrofosmin assessment of myocardial perfusion and viability in canine models of coronary occlusion and reperfusion.
    Glover DK, Ruiz M, Koplan BA, Watson DD, Beller GA.
    J Nucl Med; 1999 Jan 15; 40(1):142-9. PubMed ID: 9935070
    [Abstract] [Full Text] [Related]

  • 16. Effects of dipyridamole-induced vasodilation on myocardial uptake and clearance kinetics of thallium-201.
    Beller GA, Holzgrefe HH, Watson DD.
    Circulation; 1983 Dec 15; 68(6):1328-38. PubMed ID: 6640881
    [Abstract] [Full Text] [Related]

  • 17. Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile.
    Sinusas AJ, Trautman KA, Bergin JD, Watson DD, Ruiz M, Smith WH, Beller GA.
    Circulation; 1990 Oct 15; 82(4):1424-37. PubMed ID: 2401074
    [Abstract] [Full Text] [Related]

  • 18. Effects of residual stenosis on infarct size and regional transmural myocardial blood flow after reperfusion.
    Wilson JL, Ramanathan KB, Ingram LA, Mirvis DM.
    Am Heart J; 1988 Dec 15; 116(6 Pt 1):1523-9. PubMed ID: 3195437
    [Abstract] [Full Text] [Related]

  • 19. Assessment of myocardial viability using 123I-labeled iodophenylpentadecanoic acid at sustained low flow or after acute infarction and reperfusion.
    Yang JY, Ruiz M, Calnon DA, Watson DD, Beller GA, Glover DK.
    J Nucl Med; 1999 May 15; 40(5):821-8. PubMed ID: 10319757
    [Abstract] [Full Text] [Related]

  • 20. Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis.
    Przyklenk K, Kloner RA.
    Cardiovasc Res; 1993 Jun 15; 27(6):925-34. PubMed ID: 8221780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.